Acer Therapeutics Inc (ACER)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

ONE GATEWAY CENTER (300 WASHINGTON ST.) NEWTON, MA 02458

Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer's pipeline includes four programs: ACER-001 (a taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metaboli® including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); emetine hydrochloride, a host-directed therapy against a variety of infectious diseases, initially for the treatment of patients with COVID-19; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant for the treatment of induced Vasomotor Symptoms (iVMS). Each of Acer's product candidates is believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA.

Data as of 2021-06-19 11:33:16 -0400
Market Cap41.214 Million Shares Outstanding14.31 Million Avg 30-day Volume94.473 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.57 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.16534 52-week High/Low5.84 / 2.15 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ACER instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 31 31 0.0% 8 (0.47%) 9 (0.52%) -11.11%
13F shares: 1.655 Million 2.531 Million -34.6% 1.173 Million 1.715 Million -31.61%
% Ownership 11.5664 20.6012 -43.86% 8.1963 13.9601 -41.29%
New Positions: 7 8 -12.5% 2 3 -33.33%
Increased Positions 7 2 250.0% 2
Closed Positions 7 5 40.0% 3 1 200.0%
Reduced Positions 7 8 -12.5% 3 3 0.0%
Total Calls 48.301 Thousand 18.6 Thousand
Total Puts 34.874 Thousand 52 66965.38%
PUT/CALL Ratio 0.72 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ACER (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACER BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DAVIS JEFFERSON E CHIEF BUSINESS OFFICER

  • Officer
0 2021-02-03 2

SCHELLING CHRIS PRESIDENT & CEO

  • Officer
  • Director
  • 10% Owner
0 2021-01-15 2

PALMIN HARRY S CHIEF OPP. AND FINANCIAL OFFR

  • Officer
0 2021-01-15 1

ASELAGE STEVE

  • Director
0 2021-01-15 2

AMELLO JASON

  • Director
0 2021-01-15 1

GRIFFIN MICHELLE RENEE

  • Director
0 2021-01-15 1

DUNN JOHN MICHAEL

  • Director
0 2021-01-15 2

JOSEPH DONALD CHIEF LEGAL OFFICER AND SECY

  • Officer
0 2021-01-15 2

SEIBT MATTHEW CHIEF COMMERCIAL OFFICER

  • Officer
0 2021-01-15 1

KLOPP JOHN MICHAEL CHIEF TECHNICAL OFFICER

  • Officer
0 2021-01-15 1

ANDREWS WILLIAM T. CHIEF MEDICAL OFFICER

  • Officer
5,858 2020-03-02 0

JUTT-EGHBALI SALMA CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-12-04 0

TVM LIFE SCIENCE VENTURES VII L.P.

BIRNER HUBERT

MARENGERE LUC

FISCHER STEFAN

SCHUHSLER HELMUT

BEEBY RESHENTHA

LEATT GARY

  • Director
  • 10% Owner
1,697,709 2018-08-01 0

TVM LIFE SCIENCE VENTURES VI GMBH & CO KG

TVM LIFE SCIENCE VENTURES VI LP

TVM LIFE SCIENCE VENTURES VII L.P.

BIRNER HUBERT

MARENGERE LUC

FISCHER STEFAN

SCHUHSLER HELMUT

WANLESS MARK

LEATT GARY

  • Director
  • 10% Owner
2,397,309 2017-12-12 0

STEINER ROBERT D CHIEF MEDICAL OFFICER

0 2017-09-19 0

BARABE TIMOTHY C

  • Director
12,910 2016-11-18 0

MADERIS GAIL J

  • Director
25,884 2016-09-30 0

RICHMAN MICHAEL

  • Director
25,884 2016-09-30 0

SEAMAN SCOTT B

  • Director
159,665 2016-09-30 0

WARMA NEIL K PRESIDENT, CEO AND ACTING CFO

  • Officer
  • Director
0 2016-05-16 0

RILL DONNA R CHIEF DEVELOPMENT OFFICER

  • Officer
0 2016-05-16 0

HEALEY DON CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-05-16 0

RADHAKRISHNAN KARTHIK CHIEF FINANCIAL OFFICER

  • Officer
124,659 2015-04-08 0

HARTUNG HANS-PETER

  • Director
0 2015-03-30 0

JORDEN DAVID EMERSON

  • Director
293,456 2013-09-24 0

THOMPSON JAYE SVP CLINICAL DEV & REG AFFAIRS

  • Officer
0 2012-09-12 0

HUNG DAVID

  • Director
0 2011-04-05 0

MCWILLIAMS DAVID

  • Director
0 2009-08-26 0

SHEEDY CHARLES E

  • 10% Owner
752,354 2009-04-14 0

WILLIAMS JIMMY CALVIN CHIEF OPERATING OFFICER

  • Officer
0 2009-02-06 0

HOHLFELD LYNNE CFO

  • Officer
0 2009-01-16 0

ROTH MICHAEL

STARK BRIAN JAY

  • 10% Owner
No longer subject to file 2008-09-19 0

MARXE AUSTIN W & GREENHOUSE DAVID M

  • 10% Owner
746,848 2008-09-02 0

BAILEY GREGORY

  • Director
0 2008-06-26 0

RANDALL LORIN

  • Director
0 2008-06-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACER THERAPEUTICS INC ACER 2021-06-24 15:45:03 UTC -19.0065 19.0865 150000
ACER THERAPEUTICS INC ACER 2021-06-24 15:15:03 UTC -19.0065 19.0865 150000
ACER THERAPEUTICS INC ACER 2021-06-24 14:45:03 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-24 14:15:02 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-24 13:45:03 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-24 13:15:02 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-24 12:45:03 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-23 22:15:03 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-23 21:45:03 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-23 21:15:03 UTC -18.7294 18.8094 150000
ACER THERAPEUTICS INC ACER 2021-06-23 20:45:02 UTC -18.6951 18.7751 150000
ACER THERAPEUTICS INC ACER 2021-06-23 20:15:04 UTC -18.6951 18.7751 150000
ACER THERAPEUTICS INC ACER 2021-06-23 19:45:03 UTC -18.6951 18.7751 150000
ACER THERAPEUTICS INC ACER 2021-06-23 19:15:03 UTC -18.6951 18.7751 150000
ACER THERAPEUTICS INC ACER 2021-06-23 18:45:02 UTC -17.2133 17.2933 150000
ACER THERAPEUTICS INC ACER 2021-06-23 18:15:03 UTC -17.2133 17.2933 150000
ACER THERAPEUTICS INC ACER 2021-06-23 17:45:02 UTC -17.2133 17.2933 150000
ACER THERAPEUTICS INC ACER 2021-06-23 17:15:03 UTC -17.2133 17.2933 150000
ACER THERAPEUTICS INC ACER 2021-06-23 16:45:03 UTC -17.2133 17.2933 150000
ACER THERAPEUTICS INC ACER 2021-06-23 16:15:03 UTC -17.2133 17.2933 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments